Novartis | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 3.32B 2.71B 2024-12
Alcon AG USD 21.55B 164M 2024-12
Almirall EUR 1.49B 1.81M 2024-12
Amgen USD 6.21B 330M 2025-03
AstraZeneca USD 41.04B 168M 2025-03
Autolus Therapeutics Ltd 371.11M 56.22M 2025-03
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.98B 262.7M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Fresenius EUR 19.41B 135M 2025-03
Fresenius Medical Care EUR 15.5B 928.44M 2025-03
Galapagos EUR 2.75B 149.05M 2025-03
Genmab DKK 5.3B 31.4B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
GRIFOLS EUR 5.64B 244.27M 2025-03
Hikma Pharmaceutical USD 2.29B 88M 2024-06
J&J USD 78.11B 6.62B 2025-03
Lonza CHF 9.33B 23M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Merck USD 48.34B 2.02B 2025-03
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Novo Nordisk 138.54B 18.02B 2025-03
Orion EUR 1.07B 61.8M 2025-03
Pfizer USD 90.34B 2.14B 2025-03
Philips EUR 11.7B 309M 2025-03
Recordati EUR 1.98B 100.9M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
UCB EUR 10.03B 1.08B 2024-12



Novartis Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.